Terumo (OTCMKTS:TRUMY) Shares Gap Down – Should You Sell?

Terumo Corp. (OTCMKTS:TRUMY)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $15.50, but opened at $14.53. Terumo shares last traded at $15.04, with a volume of 3,307 shares.

Analyst Ratings Changes

Separately, Nomura raised shares of Terumo from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, Terumo presently has a consensus rating of “Buy”.

Terumo Trading Down 3.5%

The company has a debt-to-equity ratio of 0.06, a current ratio of 1.59 and a quick ratio of 0.97. The stock has a market cap of $22.07 billion, a P/E ratio of 21.08 and a beta of 0.68. The business’s 50 day simple moving average is $14.85 and its 200 day simple moving average is $13.94.

Terumo (OTCMKTS:TRUMY) last posted its earnings results on Friday, August 7th. The company reported $0.30 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.13. Terumo had a net margin of 13.83% and a return on equity of 10.55%. The business had revenue of $1.97 billion for the quarter, compared to analyst estimates of $1.84 billion. On average, analysts expect that Terumo Corp. will post 0.7 earnings per share for the current fiscal year.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.